CN116621732B - 一种2-氰基-2-丙戊酸酯及其制备方法与应用 - Google Patents
一种2-氰基-2-丙戊酸酯及其制备方法与应用 Download PDFInfo
- Publication number
- CN116621732B CN116621732B CN202210132037.4A CN202210132037A CN116621732B CN 116621732 B CN116621732 B CN 116621732B CN 202210132037 A CN202210132037 A CN 202210132037A CN 116621732 B CN116621732 B CN 116621732B
- Authority
- CN
- China
- Prior art keywords
- cyano
- valproate
- catalyst
- reaction
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 49
- 229960000604 valproic acid Drugs 0.000 title claims description 36
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 claims abstract description 64
- 238000006243 chemical reaction Methods 0.000 claims abstract description 50
- 229940102566 valproate Drugs 0.000 claims abstract description 42
- 229940084026 sodium valproate Drugs 0.000 claims abstract description 25
- 239000003054 catalyst Substances 0.000 claims abstract description 24
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims abstract description 24
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 claims abstract description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940023568 magnesium valproate Drugs 0.000 claims abstract description 10
- LKLLHOIUJVEAGU-UHFFFAOYSA-L magnesium;2-propylpentanoate Chemical compound [Mg+2].CCCC(C([O-])=O)CCC.CCCC(C([O-])=O)CCC LKLLHOIUJVEAGU-UHFFFAOYSA-L 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 6
- MLIREBYILWEBDM-UHFFFAOYSA-M 2-cyanoacetate Chemical compound [O-]C(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-M 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical group COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims abstract description 3
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 36
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical group [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 13
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 10
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 10
- 239000002585 base Substances 0.000 claims description 9
- -1 cyanoacetic acid ester Chemical class 0.000 claims description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical group [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims description 6
- NLFIMXLLXGTDME-UHFFFAOYSA-N propyl 2-cyanoacetate Chemical group CCCOC(=O)CC#N NLFIMXLLXGTDME-UHFFFAOYSA-N 0.000 claims description 5
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- BESQLCCRQYTQQI-UHFFFAOYSA-N propan-2-yl 2-cyanoacetate Chemical compound CC(C)OC(=O)CC#N BESQLCCRQYTQQI-UHFFFAOYSA-N 0.000 claims description 4
- BFNYNEMRWHFIMR-UHFFFAOYSA-N tert-butyl 2-cyanoacetate Chemical compound CC(C)(C)OC(=O)CC#N BFNYNEMRWHFIMR-UHFFFAOYSA-N 0.000 claims description 4
- MLIREBYILWEBDM-UHFFFAOYSA-N anhydrous cyanoacetic acid Natural products OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 claims description 3
- 230000003197 catalytic effect Effects 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 3
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 claims description 2
- DJACTCNGCHPGOI-UHFFFAOYSA-N butyl 2-cyanoacetate Chemical compound CCCCOC(=O)CC#N DJACTCNGCHPGOI-UHFFFAOYSA-N 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims 7
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 28
- 125000000217 alkyl group Chemical group 0.000 abstract description 18
- 229910052700 potassium Inorganic materials 0.000 abstract description 9
- 239000011734 sodium Substances 0.000 abstract description 9
- 229910052708 sodium Inorganic materials 0.000 abstract description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract description 8
- 238000006555 catalytic reaction Methods 0.000 abstract description 8
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical group COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 abstract description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract description 6
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 abstract description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003513 alkali Substances 0.000 abstract description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 abstract description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract description 2
- 239000004412 Bulk moulding compound Substances 0.000 abstract description 2
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 abstract description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 abstract 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 18
- 239000007787 solid Substances 0.000 description 16
- 238000001914 filtration Methods 0.000 description 15
- 238000005406 washing Methods 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000001035 drying Methods 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 11
- 239000003208 petroleum Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000001816 cooling Methods 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- 229910017053 inorganic salt Inorganic materials 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- DIRSQLKNZQKDBK-UHFFFAOYSA-N 2,2-dipropylpropanedioic acid Chemical compound CCCC(C(O)=O)(C(O)=O)CCC DIRSQLKNZQKDBK-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 239000001961 anticonvulsive agent Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 4
- 239000012295 chemical reaction liquid Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical group [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 3
- YCBOPMITSGZJDX-UHFFFAOYSA-N 2-propylpentanenitrile Chemical compound CCCC(C#N)CCC YCBOPMITSGZJDX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004042 decolorization Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 3
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 3
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 3
- UQFSVBXCNGCBBW-UHFFFAOYSA-M tetraethylammonium iodide Chemical compound [I-].CC[N+](CC)(CC)CC UQFSVBXCNGCBBW-UHFFFAOYSA-M 0.000 description 3
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 description 3
- RXMRGBVLCSYIBO-UHFFFAOYSA-M tetramethylazanium;iodide Chemical compound [I-].C[N+](C)(C)C RXMRGBVLCSYIBO-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229960003965 antiepileptics Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical group [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- GTDKXDWWMOMSFL-UHFFFAOYSA-M tetramethylazanium;fluoride Chemical compound [F-].C[N+](C)(C)C GTDKXDWWMOMSFL-UHFFFAOYSA-M 0.000 description 2
- QENJZWZWAWWESF-UHFFFAOYSA-N tri-methylbenzoic acid Natural products CC1=CC(C)=C(C(O)=O)C=C1C QENJZWZWAWWESF-UHFFFAOYSA-N 0.000 description 2
- PTMFUWGXPRYYMC-UHFFFAOYSA-N triethylazanium;formate Chemical compound OC=O.CCN(CC)CC PTMFUWGXPRYYMC-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000863480 Vinca Species 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- RCUIWQWWDLZNMS-UHFFFAOYSA-N benzyl 2-cyanoacetate Chemical compound N#CCC(=O)OCC1=CC=CC=C1 RCUIWQWWDLZNMS-UHFFFAOYSA-N 0.000 description 1
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000003442 catalytic alkylation reaction Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- CREVBWLEPKAZBH-UHFFFAOYSA-M hydron;tetraethylazanium;sulfate Chemical compound OS([O-])(=O)=O.CC[N+](CC)(CC)CC CREVBWLEPKAZBH-UHFFFAOYSA-M 0.000 description 1
- DWTYPCUOWWOADE-UHFFFAOYSA-M hydron;tetramethylazanium;sulfate Chemical compound C[N+](C)(C)C.OS([O-])(=O)=O DWTYPCUOWWOADE-UHFFFAOYSA-M 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- MOVBJUGHBJJKOW-UHFFFAOYSA-N methyl 2-amino-5-methoxybenzoate Chemical compound COC(=O)C1=CC(OC)=CC=C1N MOVBJUGHBJJKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- FZPXKEPZZOEPGX-UHFFFAOYSA-N n,n-dibutylaniline Chemical compound CCCCN(CCCC)C1=CC=CC=C1 FZPXKEPZZOEPGX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003408 phase transfer catalysis Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- QSUJAUYJBJRLKV-UHFFFAOYSA-M tetraethylazanium;fluoride Chemical compound [F-].CC[N+](CC)(CC)CC QSUJAUYJBJRLKV-UHFFFAOYSA-M 0.000 description 1
- SZEMGTQCPRNXEG-UHFFFAOYSA-M trimethyl(octadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C SZEMGTQCPRNXEG-UHFFFAOYSA-M 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
- C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及化学结构式Ⅰ所示的2‑氰基‑2‑丙戊酸酯的制备方法:具体是氰基乙酸酯与1‑氯丙烷在碱作用下,复合催化二丙基化制得2‑氰基‑2‑丙戊酸酯;其制备反应如下:R=苄基、C1~C5直链烷基或C3~C5支链烷基;溶剂选择:THF、DMF、DMC、DMSO、乙/丙/丁腈、1,4‑二氧六环、乙二醇二甲/乙醚、二乙二醇二甲/乙醚、乙酸乙/丁酯中的一种或二种;碱选自:粉状M2CO3;其中M=Na、Li、Cs或K;催化剂由催化剂A和催化剂B组成;催化剂A选择:R3N、PhNR2、R4NX、R3R1NX的一种或二种,其中R=C1~C5直链烷基,R1=PhCH2、C16直链烷基或C18直链烷基,X=F、Cl、Br、I或HSO4;催化剂B选自MX,其中M=Na、Li、Cs、K,X=F、Cl、Br或I。2‑氰基‑2‑丙戊酸酯(Ⅰ)在制备丙戊酸、丙戊酸钠、丙戊酸镁和丙戊酰胺中的应用。
Description
技术领域
本发明涉及一种2-氰基-2-丙戊酸酯的相转移复合催化制备方法及其在制备丙戊酸、丙戊酸钠、丙戊酸镁和丙戊酰胺中的应用。
背景技术
湖南医药工业研究所等[抗癫痫药物抗癫灵的合成方法.中国医药工业杂志,1978,1:34-35;曲迪.山东化工,2012,41(3):30-31,35]选择以丙二酸二乙酯和1-溴丙烷,经烷基化、水解、脱羧和成盐四步反应制得丙戊酸钠。
2016年宗智慧等[丙戊酸钠的合成工艺改进.长春师范大学学报,2016,08:64-67]以丙二酸二乙酯和1-溴丙烷为原料,对丙戊酸钠的制备工艺进行优化;并探究出乙酸乙酯和丙酮作为重结晶溶剂,对丙戊酸钠重结晶收率分别达96%和90%。
2016年张晶[丙戊酸钠的合成工艺,CN105622390A.2016-06-01]以丙二酸二乙酯和1-溴丙烷为原料,发明了一种丙戊酸钠的制备工艺:
2012年付金广[丙戊酸钠的合成工艺改进.山东化工,2012,41(10):3-4]选择丙二酸二甲酯,在PEG-400催化下,在甲醇钠作用下,与1-溴丙烷反应,再经氢氧化钠水解,加热脱羧,最后成盐得到丙戊酸钠。
周启群等[丙戊酸钠合成工艺改进.中国医药工业杂志.1993,24(8):347-348;王学勤,田永广.丙戊酸钠合成新工艺.中国医药工业杂志.1999,30(9):389-390]选择乙酰乙酸甲酯经TEBA固液相转移催化烷基化、脱酰基、水解、成盐制得丙戊酸钠:
1999年王学勤等[丙戊酸钠合成新工艺.中国医药工业杂志,1999,30(9):389-390]选择乙酰乙酸甲酯和碳酸钾,在TBAB催化下,与1-溴丙烷缩合得二丙基乙酰乙酸酯,收率63.1%。2019年林凡友[一种丙戊酸钠的合成工艺,CN110563572A,2019-12-13]也采用TBAB相转移催化制备一种丙戊酸钠。
1984年李辛缘等[固液相转移催化反应合成丙戊酸类抗癫痫药物.医药工业,1984,5:4-6]选择氰乙酸甲酯、1-溴丙烷和固体碳酸钾,在季铵盐催化下二丙烷基化,再经水解、脱羧和成盐制备丙戊酸钠/镁或丙戊酰胺。
2011年陶晶等[二丙基丙二酸二酯的制备方法.中国发明专利.CN103183612A,2013-07-03;一种制备2-丙基戊酸的方法,CN103183599B,2015-04-01]选择一种以丙二酸二酯和1-氯丙烷为原料制备丙戊酸,其中二丙基化反应的粗品收率70.5%。
2018年李卫国[一种丙戊酸钠的制备方法,CN201811564128.5,2020-06-3]选择戊酸乙酯为原料制备丙戊酸钠,工艺路线如下:
发明内容
本发明的目的一方面是提供化学结构式Ⅰ所示的2-氰基-2-丙戊酸酯的制备方法:其特征在于氰基乙酸酯与1-氯丙烷,在碱作用下,复合催化二丙基化制得Ⅰ所示的化合物;其制备反应如下:
R=苄基、C1~C5直链烷基或C3~C5支链烷基;
催化剂由催化剂A和催化剂B组成;
催化剂A选择:R3N、PhNR2、R4NX、R3R1NX或MX中的一种或二种;其中R=C1~C5直链烷基;R1=PhCH2、C16直链烷基或C18直链烷基;其中X=F、Cl、Br、I或HSO4;
催化剂B选择MX;其中M=Na、Li、Cs、K,X=F、Cl、Br或I。
R4NX选自:TBAF、TBAC、TBAB、TBAI、TEAF、TEAC、TEAB、TEAI、TMAF、TMAC、TMAB、TMAI、TEAHSO4、TMAHSO4或TBAHSO4;TBAF、TBAC、TBAB、TBAI或TBAHSO4分别为四丁基氟化铵、四丁基氯化铵、四丁基溴化铵、四丁基碘化铵或四丁基硫酸氢铵;TEAF、TEAC、TEAB、TEAI或TEAHSO4分别为四乙基氟化铵、四乙基氯化铵、四乙基溴化铵、四乙基碘化铵或四乙基硫酸氢铵;TMAF、TMAC、TMAB、TMAI或TMAHSO4分别为四甲基氟化铵、四甲基氯化铵、四甲基溴化铵、四甲基碘化铵或四甲基硫酸氢铵。
R3R1NX选自:1631、1831、TEBA或TMBA;1631为十六烷基三甲基溴化铵;1831为十八烷基三甲基溴化铵;TEBA为三乙基苄基氯化铵;TMBA三甲基苄基氯化铵。
R3N选自:三甲胺、三乙胺、三丙胺、三丁胺;PhNR2选自:N,N-二甲苯胺、N,N-二乙苯胺、N,N-二丙苯胺或N,N-二丁苯胺。
MX选自:NaBr、KBr、NaI或KI。
溶剂选择:THF、DMF、DMC、DMSO、乙腈、丙腈、丁腈、1,4-二氧六环、乙二醇二甲醚、乙二醇二乙醚、二乙二醇二甲醚、二乙二醇二乙醚、乙酸乙酯或乙酸丁酯中的一种或二种。
碱选自:粉状M2CO3;其中M=Na、Li、Cs或K。
粉状M2CO3选择:100目M2CO3、150目M2CO3、200目M2CO3、250目M2CO3、300目M2CO3或350目M2CO3,其中M=Na、Li、Cs或K。
反应温度选择:60℃~120℃;反应时间选择:1.0h~12h;
催化用量选择:氰基乙酸酯∶催化剂A∶催化剂B=1∶0.01~0.10∶0.005~0.05摩尔比;氰基乙酸酯选自:氰基乙酸甲酯、氰基乙酸乙酯、氰基乙酸正丙酯、氰基乙酸异丙酯、氰基乙酸正丁酯、氰基乙酸叔丁酯或氰基乙酸苄酯。
本发明的目的第二方面是提供式Ⅰ所示的2-氰基-2-丙戊酸酯在制备丙戊酰胺中应用,Ⅰ所示的2-氰基-2-丙戊酸酯经三步反应制得丙戊酰胺,其制备反应如下:
R=苄基、C1~C5直链烷基或C3~C5支链烷基;碱选自:MOH,其中M=Na、Li、Cs或K;酸选自:盐酸或硫酸。
本发明的目的第三方面是提供式Ⅰ所示的2-氰基-2-丙戊酸酯在制备丙戊酸中的应用,其特征在于选择式Ⅰ所示的2-氰基-2-丙戊酸酯经三步反应制得丙戊酸,其制备反应如下:
R=苄基、C1~C5直链烷基或C3~C5支链烷基;碱选自:MOH,其中M=Na、Li、Cs或K;酸选自:HCl,AlCl3或硫酸。
本发明的目的第四方面是提供式Ⅰ所示的2-氰基-2-丙戊酸酯在制备丙戊酸钠中的应用,其特征在于选择式Ⅰ所示的2-氰基-2-丙戊酸酯经四步反应制得丙戊酸钠,其制备反应如下:
R=苄基、C1~C5直链烷基或C3~C5支链烷基;碱选自:MOH,其中M=Na、Li、Cs或K;酸选自:HCl,AlCl3或硫酸。
本发明的目的第五方面是提供式Ⅰ所示的2-氰基-2-丙戊酸酯在制备丙戊酸镁中的应用,其特征在于选择式Ⅰ所示的2-氰基-2-丙戊酸酯经四步反应制得丙戊酸镁,其制备反应如下:
R=苄基、C1~C5直链烷基或C3~C5支链烷基;碱选自:MOH,其中M=Na、Li、Cs或K;酸选自:HCl,AlCl3或硫酸。
本发明与现有技术相比具有以下优点:
1.本发明中,采用氰基乙酸酯和1-氯丙烷的复合催化二丙基化方法:1-氯丙烷供应充足,来源丰富,且价廉;该关键性二丙基化反应完全,为最终产品高质量提供保障!四种丙戊酸及其衍生物——丙戊酸、丙戊酸钠、丙戊酸镁和丙戊酰胺共用该关键性反应;一条生产路线可生产高质量的四种丙戊酸及其衍生物:
2.本发明生产工艺路线中不使用强碱甲醇钠、乙醇钠或叔丁钾,也不使用价格较贵的1-溴丙烷;创造性地避免了下列副产物的产生:
3.工艺中的中间体和产品纯度高,分离简单;原料药生产成本低,质量好。具有很好的社会效益与经济效益。
具体实施方式
下面结合实施例对本发明进行进一步的详细说明。
实施例1
2-氰基-2-丙戊酸甲酯的制备
29.73g(0.30mol)氰乙酸甲酯、12.0mmol四丁基溴化铵、3.0mmolKI、91.21g(0.66mol)K2CO3、120ml DMF和58.91g(0.75mol)1-氯丙烷,85℃搅拌反应3.0h(TLC监测反应完成),反应毕,稍冷后过滤无机盐;石油醚洗涤无机盐;有机相用水洗涤至水相无色,无水硫酸钠干燥有机相,抽滤回收硫酸钠,旋蒸有机相,干燥得53.06g 2-氰基-2-丙戊酸甲酯,收率96.50%(以氰乙酸甲酯计);1H NMR(400MHz,DMSO-d6)δ:3.76(s,3H,OCH3),1.85–1.75(m,4H,CH2×2),1.52–1.38(m,2H,CH2),1.30–1.17(m,2H,CH2),0.91(t,J=7.2Hz,6H,CH3×2)。
实施例2
2-氰基-2-丙戊酸的制备
29.73g(0.30mol)氰乙酸甲酯、12.0mmol四丁基氯化铵、3.0mmolKI、91.21g(0.66mol)K2CO3、120ml乙二醇二甲醚和58.91g(0.75mol)1-氯丙烷,85℃搅拌反应2.5h(TLC监测反应完成),反应毕,稍冷后过滤无机盐;乙酸乙酯洗涤无机盐;无机盐为KCl和KHCO3,回收;有机相用水洗涤至水相无色,蒸溜回收乙酸乙酯,在残留的淡黄色透明液体(2-氰基-2-丙戊酸甲酯)中,加150ml 15%KOH,升温水解3h,加浓盐酸中和,析出固体,干燥得白色固体48.69g 2-氰基-2-丙戊酸,收率95.90%(以氰乙酸甲酯计),熔点49~50℃。1HNMR(400MHz,DMSO-d6)δ:13.76(s,1H,CO2H),1.84–1.67(m,4H,CH2×2),1.54–1.41(m,2H,CH2),1.36–1.21(m,2H,CH2),0.92(t,J=7.2Hz,6H,CH3×2)。
实施例3
2-氰基-2-丙戊酸的制备
29.73g(0.30mol)氰乙酸甲酯、3.33g(9.0mmol)TBAB、3.0mmolKI、91.21g(0.66mol)K2CO3、120ml DMF和58.91g(0.75mol)1-氯丙烷,85℃搅拌反应3.3h(TLC监测反应完成),反应毕,冷却,过滤无机盐;石油醚(100ml×3)洗无机盐,无机盐为KCl和KHCO3;50ml×3水洗有机相,蒸馏回收石油醚,得到淡黄色透明液体(2-氰基-2-丙戊酸酯)。在2-氰基-2-丙戊酸酯淡黄色透明液体中,加150ml 15%KOH,65℃水解3h,冰浴下加入浓盐酸中和,析出白色沉淀,过滤,干燥得白色固体49.10g 2-氰基-2-丙戊酸,收率96.72%(以氰乙酸甲酯计),熔点49~50℃。1HNMR(400MHz,DMSO-d6)δ:13.76(s,1H,CO2H),1.84–1.67(m,4H,CH2×2),1.54–1.41(m,2H,CH2),1.36–1.21(m,2H,CH2),0.92(t,J=7.2Hz,6H,CH3×2)。
实施例4
2-氰基-2-丙戊酸乙酯的制备
2.26g(20mmol)氰乙酸乙酯、1mmolTBAC、0.5mmolKI、6.08g(44mmol)K2CO3(200目)、8ml DMF和3.93g(50mmol)1-氯丙烷,80℃搅拌反应6h,过滤回收无机盐;石油醚洗涤,有机相用水洗涤至水相无色,无水硫酸钠干燥,抽滤,旋蒸,干燥得3.74g 2-氰基-2-丙戊酸乙酯,收率94.9%(以氰乙酸乙酯计)。1H NMR(400MHz,DMSO-d6)δ:4.22(q,J=7.2Hz,2H,OCH2),1.84–1.75(m,4H,CH2×2),1.52–1.39(m,2H,CH2),1.31–1.18(m,5H,CH2+CH3),0.91(t,J=7.2Hz,6H,CH3×2)。
实施例5
2-氰基-2-丙戊酸的制备
2.26g(20mmol)氰乙酸乙酯、1mmol TBAC,6.08g(44mmol)K2CO3(100目),2ml DMF、6ml乙酸丁酯和0.5mmol溴化钾,3.93g(50mmol)1-氯丙烷,80℃搅拌反应6h,过滤回收无机盐;石油醚洗涤,有机相用水洗涤至水相无色,旋蒸回收石油醚,在残留的淡黄色透明液体(2-氰基-2-丙戊酸乙酯)中,加15ml 15%KOH,升温水解3h,加浓盐酸中和,析出固体,干燥得白色固体3.13g 2-氰基-2-丙戊酸,收率92.60%(以氰乙酸乙酯计),熔点49~50℃。1HNMR(400MHz,DMSO-d6)δ:13.76(s,1H,CO2H),1.84–1.67(m,4H,CH2×2),1.54–1.41(m,2H,CH2),1.36–1.21(m,2H,CH2),0.92(t,J=7.2Hz,6H,CH3×2)。
实施例6
2-氰基-2-丙戊酸甲酯的制备
29.73g(0.30mol)氰乙酸甲酯、15.0mmol三丁胺,91.21g(0.66mol)K2CO3(300目)、120ml回收的DMF和5.0mmol碘化钾和58.91g(0.75mol)1-氯丙烷,85℃搅拌反应4.0h(TLC监测反应完成),反应毕,过滤回收无机盐;石油醚洗涤,有机相用水洗涤至水相无色,无水硫酸钠干燥,抽滤,旋蒸,干燥得53.46g 2-氰基-2-丙戊酸甲酯,收率94.36%。1H NMR(400MHz,DMSO-d6)δ:3.76(s,3H,OCH3),1.85–1.75(m,4H,CH2×2),1.52–1.38(m,2H,CH2),1.30–1.17(m,2H,CH2),0.91(t,J=7.2Hz,6H,CH3×2)。
实施例7
2-氰基-2-丙戊酸甲酯的制备
29.73g(0.30mol)氰乙酸甲酯、9.0mmol回收的四丁基溴化铵、91.21g(0.66mol)K2CO3(300目)、120ml回收的DMF、2.0mmol碘化钾和58.91g(0.75mol)1-氯丙烷,85℃搅拌反应3.0h(TLC监测反应完成),过滤回收无机盐;石油醚洗涤,有机相用水洗涤至水相无色,无水硫酸钠干燥,抽滤,旋蒸,干燥得53.46g 2-氰基-2-丙戊酸甲酯,收率94.36%。1H NMR(400MHz,DMSO-d6)δ:3.76(s,3H,OCH3),1.85–1.75(m,4H,CH2×2),1.52–1.38(m,2H,CH2),1.30–1.17(m,2H,CH2),0.91(t,J=7.2Hz,6H,CH3×2)。
实施例8
2-氰基-2-丙戊酸正丙酯的制备
按实施例1的方法选择氰乙酸正丙酯制备2-氰基-2-丙戊酸正丙酯。
实施例9
2-氰基-2-丙戊酸的制备
按实施例2的方法选择氰乙酸正丙酯制备2-氰基-2-丙戊酸。
实施例10
2-氰基-2-丙戊酸异丙酯的制备
按实施例1的方法,选择氰乙酸异丙酯制备2-氰基-2-丙戊酸异丙酯。
实施例11
2-氰基-2-丙戊酸的制备
按实施例2的方法,选择氰乙酸异丙酯制备2-氰基-2-丙戊酸。
实施例12
2-氰基-2-丙戊酸叔丁酯的制备
按实施例1的方法,选择氰乙酸叔丁酯制备2-氰基-2-丙戊酸叔丁酯。
实施例13
2-氰基-2-丙戊酸的制备
按实施例2的方法,选择氰乙酸叔丁酯制备2-氰基-2-丙戊酸。
实施例14
丙戊酸的制备
29.73g(0.30mol)氰乙酸甲酯、12.0mmol四丁基溴化铵、3.0mmolKI、91.21g(0.66mol)K2CO3(300目)、80ml乙酸丁酯、40ml DMF和58.91g(0.75mol)1-氯丙烷,85℃搅拌反应4.0h(TLC监测反应完成),反应毕,稍冷后过滤无机盐;石油醚洗涤无机盐;有机相用水洗涤至水相无色,旋蒸回收石油醚,在残液(2-氰基-2-丙戊酸甲酯)中,加甲醇,通HCl,通气完毕,搅拌反应,反应毕,反应液于65℃下滴加氢氧化钾水溶液(KOH:150g,H2O:200g),85℃回流3h,脱溶得到固体。加水250mL溶解固体,过滤除去未溶物,浓盐酸调节滤液pH1~1.5,有固体析出,抽滤干燥得49.10g 2,2-二丙基丙二酸。
按专利[一种制备2-丙基戊酸的方法,CN103183599B,2015-04-01]实施例1中的方法:将31g 2,2-二丙基丙二酸加入200mL圆底瓶中,用氮气置换三次,放入预先稳定的170℃油浴中反应,反应过程中放出CO2,3h反应完全。降温,得23g丙戊酸。HPLC结果显示,纯度为99.84%。1H NMR(400MHz,DMSO-d6)δ:11.99(s,1H,COOH),2.24–2.18(m,1H,CH),1.53–1.44(m,2H,CH2),1.39–1.34(m,2H,CH2),1.32–1.22(m,4H,CH2×2),0.86(t,J=7.2Hz,6H,CH3×2)。
实施例15
丙戊酸的制备
22.6g(200mmol)氰乙酸乙酯、10mmolTBAC,60.8g(44mmol)K2CO3(100目),80mlDMF和5.0mmol碘化钾和39.3g(50mmol)1-氯丙烷,80℃搅拌反应6h,过滤回收无机盐;石油醚洗涤,有机相用水洗涤至水相无色,旋蒸回收石油醚,在残留的淡黄色透明液体(2-氰基-2-丙戊酸乙酯)中,加乙醇,通HCl,通气完毕,搅拌反应,反应毕,反应液于65℃下滴加氢氧化钾水溶液(KOH:150g,H2O:200g),升温85℃激烈回流3h,脱溶得到固体。加水溶解固体,滴加浓盐酸调节pH为1~1.5,有固体析出,抽滤得32.4g淡黄色固体——2,2-二丙基丙二酸。
按专利[一种制备2-丙基戊酸的方法,CN103183599B,2015-04-01]实施例1中的方法:将31g 2,2-二丙基丙二酸加入200mL圆底瓶中,用氮气置换三次,放入预先稳定的170℃油浴中反应,反应过程中放出CO2,3h反应完全。降温,得23g丙戊酸。HPLC结果显示,纯度为99.84%。1H NMR(400MHz,DMSO-d6)δ:11.99(s,1H,COOH),2.24–2.18(m,1H,CH),1.53–1.44(m,2H,CH2),1.39–1.34(m,2H,CH2),1.32–1.22(m,4H,CH2×2),0.86(t,J=7.2Hz,6H,CH3×2)。
实施例16
丙戊酸钠的制备
按文献[李辛缘等.固液相转移催化反应合成丙戊酸类抗癫痫药物.医药工业,1984,5:4-6]方法制备:43g丙戊酸(实施例10或11方法制备)、12g氢氧化钠和86g水,溶解,并调节至pH8~9,加入活性炭0.4g脱色,过滤,滤液浓缩至干,即得49g 2-丙戊酸钠,收率98%(以丙戊酸计算)。
实施例17
丙戊酸镁的制备
按文献[李辛缘等.固液相转移催化反应合成丙戊酸类抗癫痫药物.医药工业,1984,5:4-6]方法制备:在反应釜中加入500ml水和5g氧化镁,搅拌下升温至40℃,缓缓加入25g丙戊酸(实施例10或11方法制备),升温至70℃,反应1h。反应毕,加入活性炭0.5g脱色,压滤,滤液浓缩,干燥得26g 2-丙戊酸镁,收率96%。
实施例18
丙戊酰胺的制备
按文献[李辛缘.新型抗癫痫药物—丙缬草酰胺的合成,医药工业,1981,(11):1-2]方法制备:
(1)2-丙基戊腈的制备
83g 2-氰基-2-丙戊酸(实施例2或7方法制备)加入250ml圆底烧瓶中,升温至145~150℃,回流3h,分馏,收集165~175℃馏分,得无色油状物2-丙基戊腈,折纯收率70%。
(2)丙戊酰胺的制备
500ml三颈圆底烧瓶中,加62g 2-丙基戊腈,搅拌下,加入145g 80%硫酸,80~82℃反应3h,反应液降至室温,倒入640ml冰水中,搅匀,1℃放置1h,滤出丙戊酰胺粗品,10%碳酸钠液洗涤至中性,干燥后得65g丙戊酰胺。
(3)精制
65g丙戊酰胺粗品和97ml乙醇,升温至70℃溶解,加入0.1g活性炭脱色,抽滤,滤液倒入900ml蒸馏水中,搅匀,1℃放置2h,滤出丙戊酰胺白色针状结晶,干燥后得53.5g丙戊酰胺。从母液中还可取得1.3g丙戊酰胺,共计54.8g丙戊酰胺,总收率57.2%。丙戊酰胺熔点125.5~126℃。1HNMR(400MHz,DMSO-d6)δ:7.26(s,1H,CONH2),6.71(s,1H,CONH2),2.18–2.10(m,1H,CH),1.47–1.36(m,2H,CH2),1.28–1.17(m,6H,CH2+CH2×2),0.85(t,J=5.8Hz,6H,CH3×2)。
实施例19
丙戊酸的制备
按实施例14或实施例15的方法,选择氰乙酸正丙酯制备2-氰基-2-丙戊酸正丙酯,在残留的淡黄色透明液体(2-氰基-2-丙戊酸正丙酯)中,加丙醇,通HCl,通气完毕,搅拌反应,反应毕,反应液于65℃下滴加氢氧化钾水溶液,升温85℃激烈回流3h,脱溶得到固体。加水溶解固体,滴加浓盐酸调节pH为1~1.5,有固体析出,抽滤得2,2-二丙基丙二酸。
按专利[一种制备2-丙基戊酸的方法,CN103183599B,2015-04-01]实施例1中的方法:将31g 2,2-二丙基丙二酸加入200mL圆底瓶中,用氮气置换三次,放入预先稳定的170℃油浴中反应,反应过程中放出CO2,3h反应完全。降温,得23g丙戊酸。HPLC结果显示,纯度99.84%。1HNMR(400MHz,DMSO-d6)δ:11.99(s,1H,COOH),2.24–2.18(m,1H,CH),1.53–1.44(m,2H,CH2),1.39–1.34(m,2H,CH2),1.32–1.22(m,4H,CH2×2),0.86(t,J=7.2Hz,6H,CH3×2)。
在本说明书中,本发明已参照其特定的实施例作了描述。但是,很显然仍可以作出各种修改和变换而不背离本发明的精神和范围。因此,说明书应被认为是说明性的而非限制性的。
Claims (8)
1.化学结构式Ⅰ所示的2-氰基-2-丙戊酸酯的制备方法:其特征在于氰基乙酸酯与1-氯丙烷在碱作用下,复合催化二丙基化制得式Ⅰ所示的化合物;其制备反应如下:
R=正丙基,异丙基,正丁基或叔丁基;催化剂由催化剂A和催化剂B组成;催化剂A选择:四丁基氯化铵、四丁基溴化铵或三丁胺;催化剂B选择溴化钾或碘化钾;
溶剂选择:DMF、DMC、二乙二醇二甲醚或乙二醇二乙醚;碱选自粉状K2CO3。
2.如权利要求1所述的2-氰基-2-丙戊酸酯的制备方法,其特征在于粉状K2CO3选择:100目K2CO3、150目K2CO3、200目K2CO3、250目K2CO3、300目K2CO3或350目K2CO3。
3.如权利要求1所述的2-氰基-2-丙戊酸酯的制备方法,其特征在于反应温度选择:60℃~120℃;反应时间选择:1.0h~12h。
4.如权利要求1所述的2-氰基-2-丙戊酸酯的制备方法,其特征在于催化用量选择:氰基乙酸酯∶催化剂A∶催化剂B=1∶0.01~0.10∶0.005~0.05摩尔比,其中氰基乙酸酯选自氰基乙酸正丙酯、氰基乙酸异丙酯、氰基乙酸正丁酯或氰基乙酸叔丁酯。
5.一种丙戊酰胺的制备方法,其特征在于经权利要求1~4任意一项所述方法制备2-氰基-2-丙戊酸酯(Ⅰ),2-氰基-2-丙戊酸酯经三步反应制得丙戊酰胺,其制备反应如下:
其中,R、催化剂、碱和溶剂的定义如权利要求1所述;
R的定义如权利要求1所述;碱选自KOH或NaOH;酸选自盐酸或硫酸。
6.一种丙戊酸的制备方法,其特征在于经权利要求1~4任意一项所述方法制备2-氰基-2-丙戊酸酯(Ⅰ),2-氰基-2-丙戊酸酯经三步反应制得丙戊酸,其制备反应如下:
其中,R、催化剂、碱和溶剂的定义如权利要求1所述;
R的定义如权利要求1所述;碱选自KOH或NaOH;酸选自HCl,AlCl3或硫酸。
7.一种丙戊酸钠的制备方法,其特征在于经权利要求1~4任意一项所述方法制备2-氰基-2-丙戊酸酯(Ⅰ),2-氰基-2-丙戊酸酯经四步反应制得丙戊酸钠,其制备反应如下:
其中,R、催化剂、碱和溶剂的定义如权利要求1所述;
R的定义如权利要求1所述;碱选自KOH或NaOH;酸选自HCl,AlCl3或硫酸。
8.一种丙戊酸镁的制备方法,其特征在于经权利要求1~4任意一项所述方法制备2-氰基-2-丙戊酸酯(Ⅰ),2-氰基-2-丙戊酸酯经四步反应制得丙戊酸镁,其制备反应如下:
其中,R、催化剂、碱和溶剂的定义如权利要求1所述;
R的定义如权利要求1所述;碱选自KOH或NaOH;酸选自HCl,AlCl3或硫酸。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210132037.4A CN116621732B (zh) | 2022-02-14 | 2022-02-14 | 一种2-氰基-2-丙戊酸酯及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210132037.4A CN116621732B (zh) | 2022-02-14 | 2022-02-14 | 一种2-氰基-2-丙戊酸酯及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116621732A CN116621732A (zh) | 2023-08-22 |
CN116621732B true CN116621732B (zh) | 2024-12-24 |
Family
ID=87612149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210132037.4A Active CN116621732B (zh) | 2022-02-14 | 2022-02-14 | 一种2-氰基-2-丙戊酸酯及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116621732B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114790151B (zh) * | 2022-02-14 | 2023-03-31 | 湖南省湘中制药有限公司 | 一种2-氰基-2-丙戊酸甲酯的复合催化制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103073424B (zh) * | 2013-01-18 | 2014-08-06 | 湖南大学 | 一种丙戊酸衍生物的中间体的绿色制备方法 |
CN113200844A (zh) * | 2021-03-29 | 2021-08-03 | 上海青平药业有限公司 | 一种丙戊酸钠的制备方法 |
-
2022
- 2022-02-14 CN CN202210132037.4A patent/CN116621732B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114790151B (zh) * | 2022-02-14 | 2023-03-31 | 湖南省湘中制药有限公司 | 一种2-氰基-2-丙戊酸甲酯的复合催化制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN116621732A (zh) | 2023-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2285765B1 (en) | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
CN102627573B (zh) | 5-氨基酮戊酸盐酸盐的合成方法 | |
CN114790151B (zh) | 一种2-氰基-2-丙戊酸甲酯的复合催化制备方法 | |
EP2462098B1 (en) | Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
CN114763319B (zh) | 一种联产丙戊酰胺和丙戊酸钠的方法 | |
CN101516865B (zh) | 氧代二苯并氧杂*乙酸的叔烷基酯 | |
CN116171270A (zh) | (s)-4-氯-2-氨基丁酸盐酸盐及(s)-4-氯-2-氨基丁酸酯的制备方法 | |
CN116768697B (zh) | 一种氯丙烷作烷化剂制备二丙基丙二酸的方法与应用 | |
CN116621732B (zh) | 一种2-氰基-2-丙戊酸酯及其制备方法与应用 | |
CN101605773B (zh) | 二苯并氧杂*化合物的制造方法 | |
CN114763328B (zh) | 一种2-氰基-2-丙戊酸的制备方法与应用 | |
EP2058294B1 (en) | Method for producing 2-(4-methoxycarbonylmethylphenoxymethyl)benzoic acid methyl ester | |
CN111004121A (zh) | 一种4-烷氧基乙酰乙酸酯类化合物的制备方法 | |
KR19980032744A (ko) | 발프로산의 개선된 제조방법 | |
KR101341449B1 (ko) | 디메틸 테레프탈레이트 제조공정의 부산물로부터 p-클로로메틸벤조산 및 벤조산의 제조방법 | |
WO2004005241A1 (en) | Process for producing optically active amide | |
WO2004087640A1 (en) | Process for the manufacture of n-alkoxalyl-alaninates | |
Wu et al. | CuLi2Cl4 catalysed cross-coupling strategy for the formal synthesis of the diterpenoid (+)-subersic acid from (–)-sclareol | |
JP2008074837A (ja) | 2−(4−カルボキシメチルフェノキシメチル)安息香酸化合物およびジベンゾオキセピン酢酸化合物の製造方法 | |
JP5205971B2 (ja) | テトラヒドロピラン化合物の製造方法 | |
JP5139016B2 (ja) | オキソジベンゾオキセピン酢酸第3級アルキルエステルの製造方法 | |
KR100516383B1 (ko) | 디히드로카보스트릴 유도체의 신규 제조방법 | |
JP4368494B2 (ja) | カルボン酸3級アルキルエステルの製造方法 | |
KR100699457B1 (ko) | 디벤조티에핀 유도체 및 그 중간체의 제조방법 | |
KR100501993B1 (ko) | 페닐프로피온산 유도체 또는 그의 염의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |